CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $45,326,000 | +7.7% | 1,341,000 | -25.5% | 1.15% | -8.2% |
| Q1 2021 | $42,102,000 | -18.1% | 1,800,000 | +0.8% | 1.25% | -17.7% |
| Q4 2020 | $51,408,000 | +158.9% | 1,785,000 | +82.1% | 1.52% | +71.3% |
| Q3 2020 | $19,855,000 | -32.6% | 980,000 | 0.0% | 0.89% | -49.0% |
| Q2 2020 | $29,449,000 | -4.4% | 980,000 | 0.0% | 1.74% | -46.7% |
| Q1 2020 | $30,801,000 | -46.1% | 980,000 | -19.2% | 3.27% | -37.8% |
| Q4 2019 | $57,132,000 | -99.4% | 1,212,734 | -20.4% | 5.25% | +415.6% |
| Q3 2019 | $9,844,782,000 | -47.4% | 1,523,960 | 0.0% | 1.02% | -41.8% |
| Q2 2019 | $18,714,229,000 | +88605.6% | 1,523,960 | -2.1% | 1.75% | -24.4% |
| Q1 2019 | $21,097,000 | +237.9% | 1,556,999 | +0.0% | 2.32% | +116.9% |
| Q4 2018 | $6,244,000 | -29.4% | 1,556,998 | +18.4% | 1.07% | -0.7% |
| Q3 2018 | $8,848,000 | – | 1,314,743 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |